CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Q3 2025 vs. Q2 2025
How the institutions holding CDT Equity Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 14 | 10 | −4 |
| Shares | 20.6K | 160.6K | +140.0K (+680.3%) |
| Value | $56.4K | $109.2K | +$52.7K (+93.4%) |
New holders (2)
Institutions that held CDT Equity Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Apollon Wealth Management, LLC | 107,454 | $73.1K | 0.00% |
| Citadel Advisors LLC | 35,609 | $24.2K | 0.00% |
Sold out (6)
Institutions that held CDT Equity Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| FMR LLC | 4,527 | $12.5K |
| Deutsche Bank AG | 294 | $811 |
| EverSource Wealth Advisors, LLC | 18 | $50 |
| Wells Fargo & Company | 10 | $28 |
| Sterling Capital Management LLC | 10 | $28 |
| Mirae Asset Global ETFs Holdings Ltd. | 6 | $17 |